Loeys-Dietz syndrome: genes and variants
Explore variant evidence for Loeys-Dietz syndrome across 6 analyzed proteins (TGFBR2, TGFBR1, TGFB2, SMAD2, ABCA3 and 1 more). Linked ClinVar records include 83 pathogenic or likely pathogenic variants, 431 variants of uncertain significance and 68 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Loeys-Dietz syndrome
TGFBR2: TGF-beta receptor type-2
It binds TGF-beta ligands and activates TGFBR1 to initiate canonical and noncanonical signaling. Germline pathogenic variants cause Loeys-Dietz syndrome type 2, while somatic loss can remove growth-suppressive TGF-beta responses in cancer.
49 ClinVar pathogenic / likely pathogenic and 208 uncertain variants in TGFBR2 have source records linked to Loeys-Dietz syndrome. Association strength is not clinical gene validity.
TGFBR1: TGF-beta receptor type-1
After activation by the ligand-bound receptor complex, it phosphorylates SMAD2 and SMAD3 to propagate TGF-beta signals. Germline pathogenic variants cause Loeys-Dietz syndrome type 1 with arterial aneurysm and dissection and variable craniofacial or skeletal features.
23 ClinVar pathogenic / likely pathogenic and 107 uncertain variants in TGFBR1 have source records linked to Loeys-Dietz syndrome. Association strength is not clinical gene validity.
TGFB2: Transforming growth factor beta-2 proprotein
Its secreted signaling regulates extracellular matrix, cell differentiation, proliferation, and cardiovascular development. Haploinsufficiency causes a Loeys-Dietz-spectrum connective-tissue disorder with increased risk of thoracic aortic aneurysm and dissection.
6 ClinVar pathogenic / likely pathogenic and 181 uncertain variants in TGFB2 have source records linked to Loeys-Dietz syndrome. Association strength is not clinical gene validity.
SMAD2: SMAD family member 2
It carries activated TGF-beta and activin signals from receptors to the nucleus and regulates developmental and extracellular-matrix gene programs. Heterozygous pathogenic variants can cause syndromic thoracic aortic aneurysm and dissection with variable craniofacial and cardiovascular features.
4 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in SMAD2 have source records linked to Loeys-Dietz syndrome. Association strength is not clinical gene validity.
ABCA3: Phospholipid-transporting ATPase ABCA3
It transports phospholipids into lamellar bodies of alveolar type II cells, supporting pulmonary surfactant assembly and normal gas exchange. Biallelic loss-of-function variants can cause neonatal respiratory failure or childhood interstitial lung disease.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ABCA3 have source records linked to Loeys-Dietz syndrome. Association strength is not clinical gene validity.
SMAD3: SMAD family member 3
It carries TGF-beta receptor signals into the nucleus to control extracellular-matrix, differentiation, and growth programs. Heterozygous loss-of-function variants cause Loeys-Dietz syndrome type 3 with arterial aneurysm and dissection risk and often early osteoarthritis.
0 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in SMAD3 have source records linked to Loeys-Dietz syndrome. Association strength is not clinical gene validity.
Where Loeys-Dietz syndrome variants cluster
- TGFBR2 Protein kinase (positions 244–544): 38 of 38 ClinVar pathogenic / likely pathogenic variants, 1.9× more than its size predicts (a length-based count, not a validated hotspot).
- TGFBR1 Protein kinase (positions 205–495): 21 of 22 ClinVar pathogenic / likely pathogenic variants, 1.6× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Loeys-Dietz syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| TGFBR1 R487Q | 487 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 G357E | 357 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R460P | 460 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R460L | 460 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R460H | 460 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R528H | 528 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R528C | 528 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R537C | 537 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFB2 R302C | 302 | Pathogenic / likely pathogenic (★★) | |
| TGFB2 R302S | 302 | Pathogenic / likely pathogenic (★★) | |
| TGFB2 R302H | 302 | Pathogenic / likely pathogenic (★★) | |
| TGFBR1 G214S | 214 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR1 R487W | 487 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 M434K | 434 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 D446N | 446 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 C461Y | 461 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R537H | 537 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| SMAD2 Y406C | 406 | MH2 | Pathogenic / likely pathogenic (★★) |
| TGFB2 R320C | 320 | Pathogenic / likely pathogenic (★★) | |
| TGFBR1 G312S | 312 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R254H | 254 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 C393R | 393 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 M425V | 425 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 Y470D | 470 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR1 H315Y | 315 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR1 D400N | 400 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 W287R | 287 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R356P | 356 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 M434V | 434 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFB2 R299W | 299 | Pathogenic / likely pathogenic (★★) | |
| TGFBR1 S241L | 241 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 G420V | 420 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| ABCA3 P147L | 147 | Pathogenic / likely pathogenic (★★) | |
| TGFBR1 R225G | 225 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR1 D266G | 266 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 K277N | 277 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 G351D | 351 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R378S | 378 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 D411N | 411 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 D446Y | 446 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR2 R460S | 460 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR2 R528L | 528 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR2 R528S | 528 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR2 R537S | 537 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR1 G214R | 214 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR2 G357R | 357 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR2 C461R | 461 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR2 Q444P | 444 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR2 A531D | 531 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR1 G217E | 217 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR1 K490E | 490 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR2 W287S | 287 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR2 R433S | 433 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR2 E311K | 311 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR2 D411Y | 411 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR2 E431K | 431 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR2 E456K | 456 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFB2 P338H | 338 | Pathogenic / likely pathogenic (★) | |
| TGFBR1 A230T | 230 | Protein kinase | Pathogenic / likely pathogenic (★) |
| TGFBR1 W277R | 277 | Protein kinase | Pathogenic / likely pathogenic (★) |
Showing 60 of 83.
Uncertain variants prioritized for review in Loeys-Dietz syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| TGFBR2 C393G | 393 | Protein kinase | Conflicting reports (★) | +7: C393R at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.944 |
| TGFBR2 A531T | 531 | Protein kinase | Conflicting reports (★) | +7: 5 other pathogenic changes within 3 positions; A531D at the same position is pathogenic; seen in 2e-06 of gnomAD DNA copies; REVEL 0.837 |
| TGFBR2 R254C | 254 | Protein kinase | Conflicting reports (★) | +7: in a 3D region that tolerates change poorly (1R); R254H at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.886 |
| TGFBR2 K277E | 277 | Protein kinase | Uncertain (★) | +7: K277N at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.972 |
| TGFBR2 K277R | 277 | Protein kinase | Uncertain (★★) | +7: K277N at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.967 |
| TGFBR1 G353R | 353 | Protein kinase | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G353V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
Which prediction tools work for Loeys-Dietz syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 100 out of 100
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- VARITY: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 98 out of 100
- ESM1b (LLR): 97 out of 100
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 94 out of 100
- phyloP: 93 out of 100
- MetaSVM: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 93 out of 100
- MetaLR: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phastCons: 77 out of 100
- SpliceAI: 48 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 18 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Familial thoracic aortic aneurysm and aortic dissection also has ClinVar records linked to TGFBR2 variants; they fall in the same places as the Loeys-Dietz syndrome variants (78 pathogenic / likely pathogenic).
- Ehlers-Danlos syndrome also has ClinVar records linked to TGFBR2 variants; they fall in the same places as the Loeys-Dietz syndrome variants (4 pathogenic / likely pathogenic).
- Marfan syndrome also has ClinVar records linked to TGFBR2 variants; they fall mostly in different places as the Loeys-Dietz syndrome variants (3 pathogenic / likely pathogenic).
- Familial thoracic aortic aneurysm and aortic dissection also has ClinVar records linked to TGFBR1 variants; they fall partly in the same places as the Loeys-Dietz syndrome variants (23 pathogenic / likely pathogenic).
- Familial thoracic aortic aneurysm and aortic dissection also has ClinVar records linked to TGFB2 variants; they fall mostly in different places as the Loeys-Dietz syndrome variants (5 pathogenic / likely pathogenic).
- Interstitial lung disease due to ABCA3 deficiency also has ClinVar records linked to ABCA3 variants; they fall mostly in different places as the Loeys-Dietz syndrome variants (30 pathogenic / likely pathogenic).
- Pulmonary alveolar proteinosis also has ClinVar records linked to ABCA3 variants; they fall mostly in different places as the Loeys-Dietz syndrome variants (12 pathogenic / likely pathogenic).
Diseases related to Loeys-Dietz syndrome
- Familial thoracic aortic aneurysm and aortic dissection, also linked to SMAD3, TGFB2, TGFBR1 and TGFBR2
- Ehlers-Danlos syndrome, also linked to SMAD3, TGFB2, TGFBR1 and TGFBR2
- Marfan syndrome, also linked to TGFBR1 and TGFBR2
- Lynch syndrome, also linked to TGFBR2
- Atrial septal defect, also linked to TGFB2
- Interstitial lung disease due to ABCA3 deficiency, also linked to ABCA3
- Connective tissue disease, also linked to SMAD3
- Pulmonary alveolar proteinosis, also linked to ABCA3
- Aneurysm-osteoarthritis syndrome, also linked to SMAD3
- Familial aortopathy, also linked to TGFBR1
- Parkinson disease, also linked to TGFBR2
- Surfactant metabolism dysfunction, pulmonary, also linked to ABCA3
Frequently asked questions
Which genes have records linked to Loeys-Dietz syndrome?
This view contains 6 analyzed proteins: TGFBR2, TGFBR1, TGFB2, SMAD2, ABCA3 and 1 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 83 pathogenic or likely pathogenic variants, 431 variants of uncertain significance and 68 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 6 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 654 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center